Comparison of the Efficacy of Latanoprost, Bimatoprost, and Travoprost in Patients with Primary Open-Angle Glaucoma and Ocular Hypertension

Objectives: The aim of this prospective study was to compare the efficacy of latanoprost, bimatoprost, and travoprost in lowering intraocular pressure (IOP) and in preventing or delaying visual field loss in patients with primary open-angle glaucoma (POAG) and ocular hypertension (OH). Materials...

Full description

Bibliographic Details
Main Authors: Nur Çolak, Aydın Yıldırım, Haşim Uslu, Bülent Gürler
Format: Article
Language:English
Published: Galenos Yayinevi 2014-05-01
Series:Türk Oftalmoloji Dergisi
Subjects:
Online Access:http://www.oftalmoloji.org/article_6085/Comparison-Of-The-Efficacy-Of-Latanoprost-Bimatoprost-And-Travoprost-In-Patients-With-Primary-Open-angle-Glaucoma-And-Ocular-Hypertension
_version_ 1797915104615858176
author Nur Çolak
Aydın Yıldırım
Haşim Uslu
Bülent Gürler
author_facet Nur Çolak
Aydın Yıldırım
Haşim Uslu
Bülent Gürler
author_sort Nur Çolak
collection DOAJ
description Objectives: The aim of this prospective study was to compare the efficacy of latanoprost, bimatoprost, and travoprost in lowering intraocular pressure (IOP) and in preventing or delaying visual field loss in patients with primary open-angle glaucoma (POAG) and ocular hypertension (OH). Materials and Methods: The study included 124 eyes of 73 patients who were diagnosed in our clinic as having POAG or OH. All of the patients had IOP values of 22-34 mmHg, an early diagnosis of POAG or OH, without any previous treatment. The patients were randomly divided into 3 Groups: Group 1; 42 eyes treated with latanoprost (0.005%), Group 2; 40 eyes treated with bimatoprost (0.03%), and Group 3; 42 eyes treated with travoprost (0.004%). The visual field has been evaluated via the Humprey visual field evaluation of statistical program Statpac mean deviation (MD) and pattern standard deviation (PSD). The IOP, MD, and PSD values have been measured initially and at the end of the first year of treatment. Results: In comparison to the baseline, the mean changes of IOP values after one year of treatment were 6.99, 6.79 and 5.87 mmHg for the 3 Groups, respectively. The decrease in the IOP was statistically significant for each of the treatment groups (p<0.001), with insignificant differences between the groups (p>0.05). Comparison of the MD and PSD values revealed no significant differences among the treatment groups both initially and at the end of the first year (p>0.05). The mean changes in MD and PSD values at the end of the first year were similar among the treatment groups (p>0.05). Conclusion: In patients with POAG and OH, treatment with latanoprost, bimatoprost, and travoprost decrease the IOP effectively. After a one-year treatment, no significant difference has been found between the efficacy of the 3 drugs in lowering IOP and in preventing or delaying visual field loss. (Turk J Ophthalmol 2014; 44: 170-4)
first_indexed 2024-04-10T12:36:29Z
format Article
id doaj.art-90cc7228ed1a47d2bda20b71b17fbe11
institution Directory Open Access Journal
issn 1300-0659
2147-2661
language English
last_indexed 2024-04-10T12:36:29Z
publishDate 2014-05-01
publisher Galenos Yayinevi
record_format Article
series Türk Oftalmoloji Dergisi
spelling doaj.art-90cc7228ed1a47d2bda20b71b17fbe112023-02-15T16:14:37ZengGalenos YayineviTürk Oftalmoloji Dergisi1300-06592147-26612014-05-0144317017410.4274/tjo.65872Comparison of the Efficacy of Latanoprost, Bimatoprost, and Travoprost in Patients with Primary Open-Angle Glaucoma and Ocular HypertensionNur Çolak0Aydın Yıldırım1Haşim Uslu2Bülent Gürler3Fatih Üniversitesi Tıp Fakültesi, Göz Hastalıkları Anabilim Dalı, İstanbul, TürkiyeFatih Üniversitesi Tıp Fakültesi, Göz Hastalıkları Anabilim Dalı, İstanbul, TürkiyeFatih Üniversitesi Tıp Fakültesi, Göz Hastalıkları Anabilim Dalı, İstanbul, TürkiyeFatih Üniversitesi Tıp Fakültesi, Göz Hastalıkları Anabilim Dalı, İstanbul, TürkiyeObjectives: The aim of this prospective study was to compare the efficacy of latanoprost, bimatoprost, and travoprost in lowering intraocular pressure (IOP) and in preventing or delaying visual field loss in patients with primary open-angle glaucoma (POAG) and ocular hypertension (OH). Materials and Methods: The study included 124 eyes of 73 patients who were diagnosed in our clinic as having POAG or OH. All of the patients had IOP values of 22-34 mmHg, an early diagnosis of POAG or OH, without any previous treatment. The patients were randomly divided into 3 Groups: Group 1; 42 eyes treated with latanoprost (0.005%), Group 2; 40 eyes treated with bimatoprost (0.03%), and Group 3; 42 eyes treated with travoprost (0.004%). The visual field has been evaluated via the Humprey visual field evaluation of statistical program Statpac mean deviation (MD) and pattern standard deviation (PSD). The IOP, MD, and PSD values have been measured initially and at the end of the first year of treatment. Results: In comparison to the baseline, the mean changes of IOP values after one year of treatment were 6.99, 6.79 and 5.87 mmHg for the 3 Groups, respectively. The decrease in the IOP was statistically significant for each of the treatment groups (p<0.001), with insignificant differences between the groups (p>0.05). Comparison of the MD and PSD values revealed no significant differences among the treatment groups both initially and at the end of the first year (p>0.05). The mean changes in MD and PSD values at the end of the first year were similar among the treatment groups (p>0.05). Conclusion: In patients with POAG and OH, treatment with latanoprost, bimatoprost, and travoprost decrease the IOP effectively. After a one-year treatment, no significant difference has been found between the efficacy of the 3 drugs in lowering IOP and in preventing or delaying visual field loss. (Turk J Ophthalmol 2014; 44: 170-4)http://www.oftalmoloji.org/article_6085/Comparison-Of-The-Efficacy-Of-Latanoprost-Bimatoprost-And-Travoprost-In-Patients-With-Primary-Open-angle-Glaucoma-And-Ocular-HypertensionLatanoprostbimatoprosttravoprostintraocular pressurevisual field
spellingShingle Nur Çolak
Aydın Yıldırım
Haşim Uslu
Bülent Gürler
Comparison of the Efficacy of Latanoprost, Bimatoprost, and Travoprost in Patients with Primary Open-Angle Glaucoma and Ocular Hypertension
Türk Oftalmoloji Dergisi
Latanoprost
bimatoprost
travoprost
intraocular pressure
visual field
title Comparison of the Efficacy of Latanoprost, Bimatoprost, and Travoprost in Patients with Primary Open-Angle Glaucoma and Ocular Hypertension
title_full Comparison of the Efficacy of Latanoprost, Bimatoprost, and Travoprost in Patients with Primary Open-Angle Glaucoma and Ocular Hypertension
title_fullStr Comparison of the Efficacy of Latanoprost, Bimatoprost, and Travoprost in Patients with Primary Open-Angle Glaucoma and Ocular Hypertension
title_full_unstemmed Comparison of the Efficacy of Latanoprost, Bimatoprost, and Travoprost in Patients with Primary Open-Angle Glaucoma and Ocular Hypertension
title_short Comparison of the Efficacy of Latanoprost, Bimatoprost, and Travoprost in Patients with Primary Open-Angle Glaucoma and Ocular Hypertension
title_sort comparison of the efficacy of latanoprost bimatoprost and travoprost in patients with primary open angle glaucoma and ocular hypertension
topic Latanoprost
bimatoprost
travoprost
intraocular pressure
visual field
url http://www.oftalmoloji.org/article_6085/Comparison-Of-The-Efficacy-Of-Latanoprost-Bimatoprost-And-Travoprost-In-Patients-With-Primary-Open-angle-Glaucoma-And-Ocular-Hypertension
work_keys_str_mv AT nurcolak comparisonoftheefficacyoflatanoprostbimatoprostandtravoprostinpatientswithprimaryopenangleglaucomaandocularhypertension
AT aydınyıldırım comparisonoftheefficacyoflatanoprostbimatoprostandtravoprostinpatientswithprimaryopenangleglaucomaandocularhypertension
AT hasimuslu comparisonoftheefficacyoflatanoprostbimatoprostandtravoprostinpatientswithprimaryopenangleglaucomaandocularhypertension
AT bulentgurler comparisonoftheefficacyoflatanoprostbimatoprostandtravoprostinpatientswithprimaryopenangleglaucomaandocularhypertension